Intrauterine Devices Market Value is Estimated to Reach US$ 4.6 Billion by 2023 and CAGR 3.8 %

Global Intrauterine Devices Market Report, Trends, Growth, Share and Forecast Till 2023

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Intrauterine Devices Market Report By Product (Hormonal Intrauterine Device and Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare and Others), Region Over the past few years, the global intrauterine devices market has encountered moderate growth which can be accredited to supportive plans introduced by several organizations working toward educating the female population regarding the benefits of IUDs. Market Overview: As per the latest report by IMARC Group, titled “Intrauterine Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global intrauterine devices market reached a value of US$ 3.7 Billion in 2017. Intrauterine devices (IUDs) are small T-shaped contraceptive devices which are inserted into the uterus. The copper or hormones present in these devices alters the cervical mucus lining which prevents fertilization. Intrauterine devices are usually a form of long-acting reversible contraceptives (LARC) which aid in birth control for an extended period and can last for 5 to 10 years, depending on the type. They have minimal side effects when compared to other methods of contraception and are associated with less discomfort. The cost-effectiveness, high-efficiency rates and safe nature of these devices are providing a boost to the sales of intrauterine devices worldwide.

Report Description and Highlights

Report Description Market Trends:

Unintended pregnancies and unplanned births can pose a major threat to the health of a woman.

Increasing rates of unexpected pregnancies across the globe are leading women to use contraceptive methods like IUDs as a precautionary measure, thereby spurring the growth of the market. Another trend that has been witnessed among the women in developed countries is delaying pregnancy until their thirties. Due to their reversible nature, intrauterine devices are being preferred by these women as the primary method of contraception. Further, NGOs such as The International Federation of Gynaecology and Obstetrics (FIGO) are working towards improving women’s health by addressing the high maternal mortality rates in low?resource countries and encouraging women to make informed decisions about effective contraceptive methods. An increasing number of initiatives by such organizations is anticipated to propel the demand for intrauterine devices. Due to these factors, the market value is estimated to reach US$ 4.6 Billion by 2023, expanding at a CAGR of 3.8 % during 20182023.

Intrauterine Devices Market Segmentation: Market Segmentation by Product Request for a sample report: https://www.imarcgroup.com/request?type=report&id=954&flag=B

Market Forecast

Sample Figure: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion US$), 2018-2023

184.3

191.7

199.3

207.3

2018

2019

2020

2021

215.6

224.2

2022

2023

Market Segmentation

Report Description

o Hormonal Intrauterine Device o Copper Intrauterine Device On the basis of products, the market has been bifurcated into hormonal and copper IUDs. Presently, hormonal IUDs account for the largest market share, representing the most popular product type.

Market Segmentation by End-Use • • • •

Hospitals Gynaecology Clinics Community Healthcare Others

Based on end-use segments, hospitals are the major end-users of intrauterine devices, holding the dominant share. Other categories include gynaecology clinics and community healthcare centers.

Market Segmentation by Region •

North America

For more information, click here: https://www.imarcgroup.com/wearable-electronics-market

Market Segmentation

Report Description • • • •

Europe Asia Pacific Latin America Middle East and Africa

Region-wise, the market has been segmented into Europe, Asia Pacific, North America, Latin America, and Middle East and Africa. Among these, North America exhibits a clear dominance, accounting for the biggest market share.

Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players.

• • • • • • •

Actavis Bayer Teva Pharmaceutical Allergen ANI Pharmaceuticals Eurogine OCON Medical

Regional Segmentation

North America

Europ e

Asia- Pacific

Latin America

Middle East and Africa

Market Segmentation

Report Description • • • • •

Pregna SMB Corporation HLL Lifecare HRA Pharma Besins HealthCare

In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

Team Profile

Team Profile Our Team Comes From Some of the Top Universities Globally.

60% Engineering and Science

5% Others

35% Business Studies

Over 2000 Independent Consultants from different sectors.

Average Experience of 7+ Years

We are the trusted business partners to the

Partial List of Clients world's leading corporates, governments, and A partial List of our Clients institutions

We are the trusted business partners to the

Partial Listworld's of Clients leading corporates, governments, and

A partial List of our Clients

institutions

Report Description and Highlights

Report Description

© 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com